captopril has been researched along with transforming growth factor beta in 37 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 10 (27.03) | 18.2507 |
| 2000's | 18 (48.65) | 29.6817 |
| 2010's | 8 (21.62) | 24.3611 |
| 2020's | 1 (2.70) | 2.80 |
| Authors | Studies |
|---|---|
| Hamaguchi, A; Iwao, H; Kim, S; Miura, K; Ohta, K; Takaori, K; Yukimura, T | 1 |
| Chang, CC; Chuang, LY; Guh, JY; Yang, ML; Yang, YL | 1 |
| Craven, PA; DeRubertis, FR; Felder, J; Phillips, S; Studer, RK | 1 |
| Baker, KM; Bing, OH; Boluyt, MO; Brooks, WW; Conrad, CH; Crow, MT; Dostal, DE; Lakatta, EG; O'Neill, L | 1 |
| Bosch, RJ; Del Moral, RG; Iglesias, MC; Masseroli, M; O'Valle, F; Pérez-Caballero, C; Ramírez, C; Rodríguez-Puyol, D; Rodríguez-Puyol, M; Ruiz-Torres, MP | 1 |
| Ali, SM; Anderson, K; Brooks, DP; Contino, LC; Fredrickson, TA; Laping, NJ; Olson, Ba | 1 |
| Barro, C; Berthier, S; Gaudin, P; Morel, F; Trocmé, C; Zaoui, P | 1 |
| Bird, JE; Dambach, DM; Durham, SK; Giancarli, MR; Gitlitz, PH; Kopp, JB; Mozes, MM; Pandya, DG | 1 |
| Kim, HS; Oh, BH; Youn, TJ | 1 |
| Alzahabi, B; Dunn, SR; Eltayeb, BO; Lewis, EJ; McGowan, TA; Rohde, R; Sharma, K; Ziyadeh, FN | 1 |
| Cruz, CI; del Moral, RG; Rodríguez-Puyol, D; Rodríguez-Puyol, M; Ruiz-Torres, P | 1 |
| Breen, EC; Gavin, TP; Spector, DA; Wagner, H; Wagner, PD | 1 |
| Olejár, T; Poucková, P; Zadinová, M | 1 |
| Asano, T; Hayakawa, M; Miyajima, A | 1 |
| Allen, TJ; Bonnet, F; Cao, Z; Cooper, ME; Davis, B | 1 |
| Adamson, MD; Ando, Y; Clouston, AD; Horn, MJ; Jonsson, JR; Kelemen, LI; Powell, EE; Purdie, DM | 1 |
| Griffiths, NM; Naftalin, RJ; Pedley, KC; Thiagarajah, JR | 1 |
| Adam, A; Bachvarov, DR; Blais, C; Clément, R; Lapointe, N; Rouleau, JL | 1 |
| Cerullo, G; Di Paolo, S; Gesualdo, L; Grandaliano, G; Paolo Schena, F; Schena, A; Soccio, M; Stallone, G | 1 |
| Chan, LY; Chuang, TD; Guh, JY; Lai, KN; Lam, MF; Leung, JC; Tang, SC; Tsang, AW | 1 |
| Adams, DE; Boivin, GP; Brunner, HI; De Albuquerque, DA; Saxena, V; Singh, RR; Witte, DP | 1 |
| Brigstock, DR; Carretero, OA; Cavasin, MA; Peng, H; Rasoul, S; Rhaleb, NE; Sanchez-Mendoza, A; Zhuo, J | 1 |
| Faitelson, Y; Goldin, E; Latella, G; Pappo, O; Pines, M; Sestieri, M; Villanova, A; Wengrower, D; Zannineli, G; Zanninelli, G | 1 |
| Choi, SY; Ishibashi, N; Jung, SI; Kim, JM; Kim, SJ; Kim, YS; Koo, BH; Lee, JB; Min, BW; Shirouzu, K; Son, GS; Um, JW; Whang, CW | 1 |
| el-Meligi, AA; el-Semari, M; el-Shemi, N; Mahmoud, H; Soliman, AR | 1 |
| Balding, LC; Burns, WC; Burrell, LM; Candido, R; Cao, Z; Dean, RG; Twigg, SM | 1 |
| Ahn, SC; Baik, SK; Cho, MY; Choi, YH; Kim, CH; Kim, JW; Kim, MY; Kwon, SO; Park, DH; Rhim, DW | 1 |
| Gao, YY; Ji, L; Lu, Q; Wang, JY; Wu, ZM; Yin, XX | 1 |
| Bechtel, W; Bey, P; Bosukonda, D; Carlson, W; Kalluri, R; Kanasaki, K; Keck, P; LeBleu, VS; Okada, H; Rusckowski, M; Sugimoto, H; Taduri, G; Tampe, B; Tampe, D; Zeisberg, M | 1 |
| Chen, CC; Dahly-Vernon, AJ; Dunn, KM; Ledbetter, SR; Murphy, SR; Roman, RJ; Williams, JM | 1 |
| Chiou, TT; Hsu, CY; Huang, PC; Lee, CT; Lee, YT; Ng, HY; Tain, YL | 1 |
| Chen, X; Diao, TY; Gu, SS; Pan, H; Wong, MS; Zhang, FY; Zhang, Y | 1 |
| Antunes, E; Braga, GG; Costa, FTM; Dos Santos, L; Godoy, JA; Krieger, JE; Mendes, CB; Nery Diez, ACC; Pereira, DS; Vassequi-Silva, T; Vicente, CP; Werneck, CC | 1 |
| Asadikaram, G; Ebrahimi, N; Kazemi Arababadi, M; Kiani, Z; Kohan, F; Masoumi, M; Nasiri, AA; Sepehri, Z; Sheikh Fathollahi, M | 1 |
| Chen, XF; Li, XL; Liu, JX; Xu, J; Yang, M; Zhang, Y; Zhao, YY | 1 |
| Balochnejadmojarrad, T; Chamani, E; Ebadi, Z; Fadaei, R; Fallah, S; Kazemi Fard, T; Moradi, N | 1 |
| Ahmed, AA; Ahmed, AAE; El Morsy, EM; Mohamed, SK; Nofal, S | 1 |
2 trial(s) available for captopril and transforming growth factor beta
| Article | Year |
|---|---|
Captopril-induced reduction of serum levels of transforming growth factor-beta1 correlates with long-term renoprotection in insulin-dependent diabetic patients.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Captopril; Diabetes Mellitus, Type 1; Diabetic Angiopathies; Female; Follow-Up Studies; Glomerular Filtration Rate; Glycated Hemoglobin; Humans; Hypertension, Renal; Kidney Function Tests; Male; Transforming Growth Factor beta | 1999 |
Captopril enhances transforming growth factor (TGF)-beta1 expression in peripheral blood mononuclear cells: a mechanism independent from angiotensin converting enzyme inhibition? A study in cyclosporine-treated kidney-transplanted patients.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Captopril; Cyclosporine; Drug Therapy, Combination; Female; Gene Expression; Genotype; Humans; Immunosuppressive Agents; In Vitro Techniques; Kidney Transplantation; Leukocytes, Mononuclear; Male; Middle Aged; Peptidyl-Dipeptidase A; Polymorphism, Genetic; Transforming Growth Factor beta; Transforming Growth Factor beta1 | 2002 |
35 other study(ies) available for captopril and transforming growth factor beta
| Article | Year |
|---|---|
Role of angiotensin II in extracellular matrix and transforming growth factor-beta 1 expression in hypertensive rats.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta; Blood Pressure; Blotting, Northern; Captopril; Collagen; Extracellular Matrix; Gene Expression Regulation; Heart Ventricles; Hypertension; Male; Organ Size; Pyridines; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Renin-Angiotensin System; RNA, Messenger; Tetrazoles; Transforming Growth Factor beta | 1994 |
Captopril reverses high-glucose-induced growth effects on LLC-PK1 cells partly by decreasing transforming growth factor-beta receptor protein expressions.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Cell Division; Cell Size; Diabetic Nephropathies; Down-Regulation; Gene Expression Regulation; Glucose; Kidney Tubules, Proximal; LLC-PK1 Cells; Receptors, Transforming Growth Factor beta; RNA, Messenger; Swine; Transforming Growth Factor beta | 1996 |
Nitric oxide inhibition of transforming growth factor-beta and collagen synthesis in mesangial cells.
Topics: Animals; Captopril; Cattle; Cells, Cultured; Coculture Techniques; Collagen; Cyclic GMP; Dose-Response Relationship, Drug; Endothelium, Vascular; Enzyme Inhibitors; Glomerular Mesangium; Glucose; Indoles; Maleimides; Nitric Oxide; omega-N-Methylarginine; Osmolar Concentration; Penicillamine; Proline; Protein Kinase C; RNA, Messenger; S-Nitroso-N-Acetylpenicillamine; Time Factors; Transforming Growth Factor beta; Tritium | 1997 |
Captopril modifies gene expression in hypertrophied and failing hearts of aged spontaneously hypertensive rats.
Topics: Aging; Analysis of Variance; Angiotensin-Converting Enzyme Inhibitors; Angiotensinogen; Animals; Atrial Natriuretic Factor; Captopril; Cardiomegaly; Gene Expression Regulation; Heart; Heart Failure; Hypertension; Male; Myosin Heavy Chains; Polymerase Chain Reaction; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Renin; RNA, Messenger; Transcription, Genetic; Transforming Growth Factor beta | 1997 |
Age-related increase in expression of TGF-beta1 in the rat kidney: relationship to morphologic changes.
Topics: Aging; Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Immunohistochemistry; Kidney; Kidney Cortex; Kidney Glomerulus; Male; Polymerase Chain Reaction; Proteinuria; Rats; Rats, Wistar; RNA, Messenger; Transcription, Genetic; Transforming Growth Factor beta | 1998 |
Angiotensin-converting enzyme inhibition attenuates proteinuria and renal TGF-beta 1 mRNA expression in rats with chronic renal disease.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blotting, Northern; Captopril; Disease Models, Animal; Gene Expression; Kidney; Kidney Cortex; Kidney Failure, Chronic; Nephrectomy; Peptidyl-Dipeptidase A; Proteinuria; Rats; Receptors, Transforming Growth Factor beta; RNA, Messenger; Transforming Growth Factor beta | 1998 |
Human B lymphocytes synthesize the 92-kDa gelatinase, matrix metalloproteinase-9.
Topics: Androstadienes; B-Lymphocytes; Captopril; Cell Movement; Collagenases; Concanavalin A; Cytokines; Gene Expression Regulation, Enzymologic; Growth Substances; Herpesvirus 4, Human; Humans; Lipopolysaccharides; Matrix Metalloproteinase 9; RNA, Messenger; Staurosporine; Tetradecanoylphorbol Acetate; Tissue Inhibitor of Metalloproteinase-1; Transformation, Genetic; Transforming Growth Factor beta; Wortmannin | 1998 |
Captopril prevents nephropathy in HIV-transgenic mice.
Topics: AIDS-Associated Nephropathy; Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Disease Models, Animal; Female; Gene Expression; Genes, Viral; HIV-1; Humans; Kidney; Male; Mice; Mice, Transgenic; Proteinuria; RNA, Messenger; Transforming Growth Factor beta | 1998 |
Ventricular remodeling and transforming growth factor-beta 1 mRNA expression after nontransmural myocardial infarction in rats: effects of angiotensin converting enzyme inhibition and angiotensin II type 1 receptor blockade.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Echocardiography; Female; Hemodynamics; Losartan; Myocardial Infarction; Rats; Rats, Sprague-Dawley; RNA, Messenger; Transforming Growth Factor beta; Ventricular Function, Left | 1999 |
Age-related progressive renal fibrosis in rats and its prevention with ACE inhibitors and taurine.
Topics: Age Factors; Angiotensin-Converting Enzyme Inhibitors; Animals; Antioxidants; Captopril; Extracellular Matrix Proteins; Fibrosis; Kidney Cortex; Kidney Diseases; Lisinopril; Male; Rats; Rats, Inbred F344; RNA, Messenger; Taurine; Transforming Growth Factor beta | 2000 |
Effect of captopril on skeletal muscle angiogenic growth factor responses to exercise.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Endothelial Growth Factors; Female; Fibroblast Growth Factor 2; Growth Substances; Lymphokines; Motor Activity; Muscle, Skeletal; Neovascularization, Physiologic; Proto-Oncogene Proteins; Rats; Rats, Wistar; Receptor Protein-Tyrosine Kinases; Receptors, Growth Factor; Receptors, Vascular Endothelial Growth Factor; RNA, Messenger; Transforming Growth Factor beta; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-1; Vascular Endothelial Growth Factors | 2000 |
Butylaminiperindopril decreases transforming growth factor-beta 1 messenger RNA production in lungs of C57Bl6 mice after low-dose whole-body irradiation.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Female; Free Radicals; Lung; Mice; Mice, Inbred C57BL; Perindopril; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Transforming Growth Factor beta; Whole-Body Irradiation | 2000 |
Captopril restores transforming growth factor-beta type II receptor and sensitivity to transforming growth factor-beta in murine renal cell cancer cells.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Carcinoma, Renal Cell; Cell Division; Kidney Neoplasms; Mice; Receptors, Transforming Growth Factor beta; Transforming Growth Factor beta; Tumor Cells, Cultured | 2001 |
Additive hypotensive and anti-albuminuric effects of angiotensin-converting enzyme inhibition and angiotensin receptor antagonism in diabetic spontaneously hypertensive rats.
Topics: Albuminuria; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Biphenyl Compounds; Blood Pressure; Captopril; Drug Therapy, Combination; Gene Expression; Hypertension; Irbesartan; Kidney; Rats; Rats, Inbred SHR; Renin; RNA, Messenger; Tetrazoles; Transforming Growth Factor beta; Transforming Growth Factor beta1 | 2001 |
Angiotensin-converting enzyme inhibition attenuates the progression of rat hepatic fibrosis.
Topics: Analysis of Variance; Angiotensin-Converting Enzyme Inhibitors; Animals; Bile Ducts; Body Weight; Captopril; DNA, Complementary; Ligation; Liver Cirrhosis; Male; Organ Size; Rats; Rats, Inbred Lew; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Transforming Growth Factor beta | 2001 |
Evidence for modulation of pericryptal sheath myofibroblasts in rat descending colon by transforming growth factor beta and angiotensin II.
Topics: Actins; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Collagen; Colon; Diet, Sodium-Restricted; Fibroblasts; Fibrosis; Male; Radiation Injuries; Rats; Rats, Wistar; Receptors, Transforming Growth Factor beta; Sodium, Dietary; Transforming Growth Factor beta | 2002 |
Effects of captopril and omapatrilat on early post-myocardial infarction survival and cardiac hemodynamics in rats: interaction with cardiac cytokine expression.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Bradykinin Receptor Antagonists; Captopril; Coronary Circulation; Cytokines; Heart; Hemodynamics; Interleukin-10; Male; Myocardial Infarction; Myocardium; Pyridines; Rats; Rats, Wistar; Receptor, Bradykinin B1; Receptor, Bradykinin B2; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Thiazepines; Transforming Growth Factor beta; Tumor Necrosis Factor-alpha | 2002 |
Polymeric IgA1 from patients with IgA nephropathy upregulates transforming growth factor-beta synthesis and signal transduction in human mesangial cells via the renin-angiotensin system.
Topics: Captopril; Cells, Cultured; Genes, ras; Glomerular Mesangium; Glomerulonephritis, IGA; Humans; Immunoglobulin A; Losartan; Renin; Renin-Angiotensin System; RNA, Messenger; Signal Transduction; Transforming Growth Factor beta; Up-Regulation | 2003 |
An ACE inhibitor reduces Th2 cytokines and TGF-beta1 and TGF-beta2 isoforms in murine lupus nephritis.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Autoantibodies; Captopril; Chronic Disease; Cytokines; Gene Expression; Interleukin-10; Interleukin-4; Kidney; Lupus Nephritis; Mice; Mice, Inbred BALB C; Mice, Inbred MRL lpr; Mice, Inbred NZB; RNA, Messenger; Spleen; Th2 Cells; Transforming Growth Factor beta; Transforming Growth Factor beta1; Transforming Growth Factor beta2 | 2004 |
Antifibrotic effect of Ac-SDKP and angiotensin-converting enzyme inhibition in hypertension.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Captopril; Cell Division; Collagen; Connective Tissue Growth Factor; Drug Therapy, Combination; Fibrosis; Growth Inhibitors; Heart Rate; Hypertension; Hypertrophy, Left Ventricular; Immediate-Early Proteins; Intercellular Signaling Peptides and Proteins; Kidney; Macrophages; Male; Mast Cells; Monocytes; Myocardium; Myocytes, Cardiac; Oligopeptides; Rats; Rats, Sprague-Dawley; Transforming Growth Factor beta | 2004 |
Prevention of fibrosis in experimental colitis by captopril: the role of tgf-beta1.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Colitis; Colon; Disease Models, Animal; Fibrosis; Male; Rats; Transforming Growth Factor beta; Transforming Growth Factor beta1 | 2004 |
Transforming growth factor-beta1 expression and the role of angiotensin-converting enzyme inhibitor on perianastomotic intimal hyperplasia in polytetrafluoroethylene graft implanted in rabbit carotid artery.
Topics: Anastomosis, Surgical; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Vessel Prosthesis Implantation; Captopril; Carotid Artery, Common; Hyperplasia; Polytetrafluoroethylene; Rabbits; RNA, Messenger; Time Factors; Transforming Growth Factor beta; Transforming Growth Factor beta1; Tunica Intima | 2004 |
Possible new role for angiotensin-converting enzyme inhibitors in treating glomerulonephritis.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Blood Urea Nitrogen; Captopril; Case-Control Studies; Chronic Disease; Creatinine; Female; Glomerulonephritis; Humans; Hypertension; Immunoassay; Male; Middle Aged; Proteinuria; Transforming Growth Factor beta; Transforming Growth Factor beta1; Treatment Outcome | 2003 |
Connective tissue growth factor and cardiac fibrosis after myocardial infarction.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Collagen Type I; Connective Tissue Growth Factor; Fibrosis; Immediate-Early Proteins; Immunohistochemistry; In Situ Hybridization; Intercellular Signaling Peptides and Proteins; Myocardial Infarction; Myocardium; Myocytes, Cardiac; Rats; RNA, Messenger; Time Factors; Transforming Growth Factor beta; Transforming Growth Factor beta1; Ventricular Remodeling | 2005 |
[Inhibitory effect of angiotensin blockade on hepatic fibrosis in common bile duct-ligated rats].
Topics: Actins; Angiotensin II Type 1 Receptor Blockers; Animals; Bile Ducts; Captopril; Fibrosis; Hydroxyproline; Ligation; Liver; Liver Cirrhosis, Experimental; Losartan; Male; Rats; Rats, Sprague-Dawley; Transforming Growth Factor beta | 2007 |
Ginkgo biloba extract prevents glucose-induced accumulation of ECM in rat mesangial cells.
Topics: Animals; Basigin; Captopril; Cells, Cultured; Collagen Type IV; Connective Tissue Growth Factor; Diabetic Nephropathies; Extracellular Matrix; Ginkgo biloba; Glucose; Insulin-Like Growth Factor I; Laminin; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Mesangial Cells; Plant Extracts; Plasminogen Activator Inhibitor 1; Rats; Tissue Inhibitor of Metalloproteinase-1; Tissue Inhibitor of Metalloproteinase-2; Transforming Growth Factor beta | 2009 |
Activin-like kinase 3 is important for kidney regeneration and reversal of fibrosis.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Apoptosis; Bone Morphogenetic Protein Receptors; Bone Morphogenetic Protein Receptors, Type I; Bone Morphogenetic Protein Receptors, Type II; Bone Morphogenetic Proteins; Captopril; Diabetic Nephropathies; Epithelial-Mesenchymal Transition; Fibrosis; Inflammation; Kidney; Kidney Tubules; Mice; Peptide Library; Peptides; Rats; Rats, Sprague-Dawley; Regeneration; Signal Transduction; Smad3 Protein; Structure-Activity Relationship; Transforming Growth Factor beta | 2012 |
Renoprotective effects of anti-TGF-β antibody and antihypertensive therapies in Dahl S rats.
Topics: Acute Kidney Injury; Animals; Antibodies, Anti-Idiotypic; Antihypertensive Agents; Blood Pressure; Captopril; Diltiazem; Disease Models, Animal; Female; Fibrosis; Hydrochlorothiazide; Hypertension; Male; Proteinuria; Rats; Rats, Inbred Dahl; Sex Characteristics; Sodium Chloride, Dietary; Transforming Growth Factor beta | 2012 |
Renin angiotensin system blockade ameliorates lead nephropathy.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Captopril; Gene Expression Regulation; Glomerular Filtration Rate; Kidney Diseases; Lead Poisoning; Losartan; Male; Peptidyl-Dipeptidase A; Proteinuria; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; Transforming Growth Factor beta | 2013 |
Effects of angiotensin-converting enzyme inhibitor, captopril, on bone of mice with streptozotocin-induced type 1 diabetes.
Topics: Acid Phosphatase; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Bone and Bones; Bone Density; Bone Diseases, Metabolic; Captopril; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Isoenzymes; Male; Mice; Mice, Inbred DBA; NF-kappa B; Osteocalcin; Osteoclasts; Random Allocation; Renin; Renin-Angiotensin System; RNA, Messenger; Streptozocin; Tartrate-Resistant Acid Phosphatase; Tibia; Transforming Growth Factor beta; Up-Regulation | 2014 |
Losartan and captopril treatment rescue normal thrombus formation in microfibril associated glycoprotein-1 (MAGP1) deficient mice.
Topics: Animals; Antihypertensive Agents; Captopril; Carotid Arteries; Contractile Proteins; Extracellular Matrix Proteins; Gelatinases; Gene Deletion; Losartan; Male; Mice; Mice, Inbred C57BL; Platelet Aggregation; Platelet Function Tests; RNA Splicing Factors; Thrombosis; Transforming Growth Factor beta | 2016 |
Atorvastatin, Losartan and Captopril Lead to Upregulation of TGF-β, and Downregulation of IL-6 in Coronary Artery Disease and Hypertension.
Topics: Antihypertensive Agents; Atorvastatin; Captopril; Coronary Artery Disease; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Inflammation; Interleukin-6; Interleukin-8; Iran; Losartan; Transforming Growth Factor beta; Tumor Necrosis Factor-alpha; Up-Regulation | 2016 |
Inhibition on angiotensin-converting enzyme exerts beneficial effects on trabecular bone in orchidectomized mice.
Topics: Angiotensin-Converting Enzyme Inhibitors; Angiotensinogen; Animals; Bone Density; Cancellous Bone; Captopril; Carbonic Anhydrase II; Dose-Response Relationship, Drug; Femur; Lumbar Vertebrae; Male; Matrix Metalloproteinase 9; Mice; Orchiectomy; Osteoprotegerin; Proton-Translocating ATPases; RANK Ligand; Receptor, Bradykinin B1; Receptors, Cell Surface; Renin-Angiotensin System; Tibia; Transforming Growth Factor beta; Tumor Necrosis Factor-alpha | 2018 |
Captopril and Spironolactone Can Attenuate Diabetic Nephropathy in Wistar Rats by Targeting microRNA-192 and microRNA-29a/b/c.
Topics: Animals; Antihypertensive Agents; Blood Glucose; Blood Urea Nitrogen; Captopril; Creatinine; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Diuretics; Drug Combinations; Drug Repositioning; Gene Expression Regulation; Hyperglycemia; Hypoglycemic Agents; Male; MicroRNAs; Rats; Rats, Wistar; Spironolactone; Streptozocin; Transforming Growth Factor beta; Treatment Outcome | 2019 |
Targeting the adenosine monophosphate-activated protein kinase signalling pathway by bempedoic acid attenuates Angiotensin II-induced cardiac remodelling in renovascular hypertension in rats.
Topics: AMP-Activated Protein Kinases; Angiotensin II; Animals; Captopril; Hypertension; Hypertension, Renovascular; Male; Rats; Rats, Sprague-Dawley; Transforming Growth Factor beta; Ventricular Remodeling | 2023 |